Filing Flows › Bio Key International (BKYI) › Q4 2024
Bio Key International (BKYI) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Apr 23, 2025
Bio Key International (BKYI) reported revenue of $1.5M for the fourth quarter 2024 (Q4 2024), -20% from a year earlier and -32% from the quarter before. Operating margin was -86.7%, net loss $1.4M (94.7% of revenue).
Bio Key International, Q4 2024: revenue $1.5M (-20% year over year), operating margin -86.7%, net loss $1.4M, operating cash flow −$515K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | -32% | -20% |
| Operating profit | −$1.3M | — | — |
| Net earnings | −$1.4M | — | — |
| Operating cash flow | −$515K | — | — |
What changed
Revenue was $1.5M in Q4 2024, down 20% year over year and down 32% from the previous quarter. License was the largest line at 70% of revenue.
Gross margin was 82.1%. Operating costs exceeded revenue by $1.3M, an operating margin of -86.7%. The quarter ended with a net loss of $1.4M, wider than the previous quarter's $739K loss.
Operating cash flow was −$515K. Non-cash charges added back $96K of depreciation and amortization and $72K of share-based compensation. Working capital and other items added $703K. Capital expenditures of −$10K exceeded it, leaving free cash flow of −$505K.
Questions
What was Bio Key International's revenue in the fourth quarter 2024?
Bio Key International (BKYI) reported revenue of $1.5M for the fourth quarter 2024 (Q4 2024), -20% from a year earlier and -32% from the quarter before.
Was Bio Key International profitable in the fourth quarter 2024?
Operating loss was $1.3M (-86.7% of revenue) and net loss $1.4M.